Engin Kut

7PUBLICATIONS

93CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jun 26, 2026

Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study.

|May 27, 2026

First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

|Mar 23, 2026

Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study.

Osman Sütcüoğlu, Orhun Akdoğan, İlknur Deliktaş Onur

|Dec 05, 2025

Prognostic relationship of peripheral blood-immune inflammatory index (C-PLAN) in patients with high-grade glioma.

Murtaza Parvizi, Olcay Ak Nalbant, Engin Kut

|Aug 05, 2025

Evaluation of pre-treatment F-18 FDG PET/CT according to Mandard classification in locally advanced rectal cancer patients undergoing neoadjuvant chemoradiotherapy.

Feray Aras, Murtaza Parvizi, Olcay Ak Nalbant

|Jan 16, 2024

Prognostic significance of pretreatment albumin-bilirubin (ALBI) grade and platelet-albumin-bilirubin (PALBI) grade in patients with small cell lung cancer.

Engin Kut, Serkan Menekse

Pageof 2

Frequent Collaborators

Serkan Menekşe

Emine Türkmen

Murtaza Parvizi

Olcay Ak Nalbant

Musa Barış Aykan

Hasibe Bilgi Gür

Abdullah Sakin

Gül Sema Yıldıran

Elif Şahin

Nargiz Majidova

Frequent Collaborators

Serkan Menekşe

Emine Türkmen

Murtaza Parvizi

Olcay Ak Nalbant